Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of
With a rapidly rising support level converging with a hard ceiling of just over $4 a share, it appeared as though something had to give for small-cap biopharmaceutical company Cell Therapeutics
Stocks closed the day mostly higher on Tuesday, following two consecutive down-days that finished off the previous week’s trading activity. Dow Jones Industrial Average: -0.27 percent,
Shares in biotech small-cap Geron Corporation (GERN) gapped up over 100 percent to start Thursday after news that their treatment for the bone marrow disorder myelofibrosis, imelstat, showed
